NFE2L2 and liver dysplastic nodule: Moreover, a Nrf2 gene complementation assay revealed that the Nrf2 inhibitor ML385 induced ferroptosis and diminished the renoprotective effect of QCT on DN, further highlighting the crucial role of Nrf2/HO-1 signaling in the effect of QCT for treating DN progression.